Published in Thorac Cardiovasc Surg on December 01, 1988
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol (2001) 1.32
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol (2005) 1.14
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial. Ann Oncol (2000) 1.00
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J (2006) 0.99
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol (1998) 0.94
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. Lung Cancer (2012) 0.93
Pulmonary metastasizing hemangiopericytoma. Am J Clin Oncol (1988) 0.90
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol (1991) 0.88
Serum and sputum levels of cefaclor. Postgrad Med J (1979) 0.87
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer (2005) 0.86
Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Lung (1994) 0.83
Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol (1997) 0.83
[Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society]. Pneumologie (2000) 0.81
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol (2002) 0.80
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study]. Pneumologie (1998) 0.80
Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: a long-term follow-up. Eur J Cancer (1995) 0.79
[Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study]. Onkologie (1984) 0.78
[Chemotherapy of malignant pleural mesothelioma: have we made any progress?]. Zentralbl Chir (2008) 0.78
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. Eur J Cancer (1994) 0.78
[A phase II multicenter study of gemcitabine in non small cell lung cancers]. Bull Cancer (1997) 0.78
An update on European randomized studies in non-small cell lung cancer. Semin Oncol (1998) 0.77
[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)]. Pneumologie (2004) 0.77
Treatment of cancer weight loss in patients with advanced lung cancer. Oncology (1992) 0.77
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. Onkologie (1990) 0.76
Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study. Ann Oncol (2001) 0.75
Airway responsiveness to methacholine does not change during chemotherapy in patients with chronic bronchitis and bronchial carcinoma. Am Rev Respir Dis (1989) 0.75
[Non-small-cell carcinoma of the lung with invasive Aspergillus infection after chemotherapy]. Dtsch Med Wochenschr (2011) 0.75
[Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer]. Pneumologie (2011) 0.75
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer. Anticancer Drugs (2000) 0.75
[Acute exogenous allergic alveolitis--6 cases after loading mouldy barley]. Prax Klin Pneumol (1981) 0.75
[Tracheal stenoses--observations on the functional course following surgical correction]. Prax Klin Pneumol (1984) 0.75
[Chemotherapy of inoperable endothoracic tumours (results of the Karrer and aco polycytostatic therapy) (author's transl)]. Prax Klin Pneumol (1979) 0.75
[Bronchial carcinoma: demands on the clinician and radiologist]. Rontgenblatter (1988) 0.75
[Phase III therapy study in patients with small cell bronchial cancer]. Onkologie (1988) 0.75
[Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)]. Prax Klin Pneumol (1980) 0.75
[Discrepancy between the cytologic and histologic classification of bronchial cancer]. Prax Klin Pneumol (1985) 0.75
Chemotherapy (CAV) and surgical resection as combined modality in the therapy of small-cell lung cancer. Panminerva Med (1986) 0.75
Clinical and functional development of sarcoidosis considering the results of bronchoalveolar lavage. Panminerva Med (1987) 0.75
Difficulties in carboplatin dosage due to different methods of serum creatinine determination. Lung Cancer (2002) 0.75
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. Onkologie (1985) 0.75
Formation of benzo[a]pyrene-DNA adducts in blood monocytes from lung cancer patients with a familial history of lung cancer. J Cancer Res Clin Oncol (1992) 0.75
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma. Lung Cancer (2003) 0.75
[Carboplatin-Vepeside in the treatment of non-small cell bronchial cancers. A phase II study]. Pneumologie (1990) 0.75
[Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study]. Pneumologie (1990) 0.75
Somatostatin receptor scintigraphy in the staging of small cell lung cancer. Nucl Med Commun (1996) 0.75
[Possibilities of chemotherapy in patients with bronchial cancer]. Rontgenblatter (1988) 0.75
[Several years of follow-up and results of chemotherapy of small cell bronchial carcinoma]. Prax Klin Pneumol (1983) 0.75
Megestrol acetate in cachectic patients with advanced bronchogenic cancer. Onkologie (1990) 0.75
[Diagnosis, clinical aspects and therapy of bronchial adenoma with endoscopic examples]. Prax Klin Pneumol (1983) 0.75
Gemcitabine and etoposide in small cell lung cancer: phase I and II trials. Semin Oncol (1997) 0.75
[Improvement of ventilation in patients with restrictive and irreversible obstructive ventilation disorders by a single dose of theophylline]. Prax Klin Pneumol (1985) 0.75
[Bronchiectasis in Kartagener's syndrome. Indication for surgical therapy?]. Monatsschr Kinderheilkd (1983) 0.75